Hem › Steatotisk leversjukdom › Texas › San Antonio
Kliniska studier för Steatotisk leversjukdom i San Antonio, TX
17 studier för Steatotisk leversjukdom söker deltagare vid platser i och runt San Antonio (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
RekryterarFas 3
- 89bio Clinical Study Site, San Antonio
- 89bio Clinical Study Site, San Antonio
- 89bio Clinical Study Site, San Antonio
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
RekryterarFas 3
- 89bio Clinical Study Site, San Antonio
- 89bio Clinical Study Site, San Antonio
- 89bio Clinical Study Site, San Antonio
- och 2 fler
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
RekryterarFas 3
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
RekryterarFas 3
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
RekryterarFas 2
- American Research Corporation at The Texas Liver Institute, San Antonio
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
RekryterarFas 2
- American Research Corporation at The Texas Liver Institute, San Antonio
- Pinnacle Clinical Research - San Antonio, San Antonio
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
RekryterarFas 3
- American Research Corporation at Texas Liver Institute, San Antonio
- Clinical Trials of Texas, LLC dba Flourish Research, San Antonio
- IMA Clinical Research San Antonio, San Antonio
- och 1 fler
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
RekryterarFas 3
- Akero Clinical Study Site, San Antonio
- Akero Clinical Study Site, San Antonio
- Akero Clinical Study Site, San Antonio
- och 2 fler
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
RekryterarFas 3
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
RekryterarFas 2
- Quality Research, Inc., San Antonio
- Pinnacle Clinical Research - South San Antonio, San Antonio
- Pinnacle Clinical Research, San Antonio
Quantifying Hepatic Mitochondrial Fluxes in Humans
RekryterarFas 4
- Texas Diabetes Institute - University Health System, San Antonio
- University of Texas Health Science Center at San Antonio, San Antonio
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
RekryterarFas 2
- GSK Investigational Site, San Antonio
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
RekryterarFas 3
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
RekryterarFas 2
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
RekryterarFas 1
- GSK Investigational Site, San Antonio
Evaluating the Pharmacokinetics and Safety of Miricorilant
RekryterarFas 1
- Site# 433, San Antonio
Evaluation of Non-Invasive Tests for Metabolic Liver Disease
RekryterarObservationsstudie
- Endeavor Clinical Trials, San Antonio
Steatotisk leversjukdom-studier i andra städer
- New York City, NY16 studier
- Miami, FL16 studier
- San Diego, CA14 studier
- Austin, TX13 studier
- Houston, TX13 studier
- Richmond, VA12 studier
- Tucson, AZ10 studier
- Chandler, AZ10 studier
- Hialeah, FL9 studier
- Dallas, TX9 studier
- Orlando, FL9 studier
- St. Louis, MO9 studier
Andra studier i San Antonio
- Icke-småcellig lungcancer59 studier
- Bröstcancer47 studier
- Kolorektal cancer46 studier
- Metastaserande cancer44 studier
- Cancer (alla typer)41 studier
- Övervikt40 studier
- Typ 2-diabetes37 studier
- Övervikt34 studier
- Äggstockscancer31 studier
- Bukspottkörtelcancer31 studier
- Prostatacancer28 studier
- Endometriecancer27 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.